-
1. The isobutyryl shikonin compound has been shown to have anticancer properties.
异丁酰基紫杉醇化合物已被证明具有抗癌症性质。
-
2. The drug was developed to treat cancer patients with the isobutyryl shikonin compound.
该药物被开发出来，用于治疗使用异丁酰基紫杉醇化合物的癌症患者。
-
3. Due to its anticancer effects, isobutyryl shikonin is being studied for potential use in cancer treatment.
由于其抗癌症效果，异丁酰基紫杉醇正在研究中，以期在癌症治疗中的潜在应用。